BOSTON — November 7, 2025 — PathAI, a global leader in AI-powered pathology, today announced five poster presentations at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting 2025, taking place November 7–11 in Washington, DC. PathAI collaborators will present new findings from AI-enabled histology that deepen understanding of liver disease biology and treatment response.
Attendees can meet the PathAI team and see product demonstrations at Booth #926.
Featured Posters
- Collaborator: GSK
- Poster Number: 1495
- Date and Time: Friday, November 7 from 1:00-2:00 p.m. E.T.
Title: Serum Multiomics Predicts Liver Histopathology and Disease Prognosis in MASH
- Collaborator: GSK
- Poster Number: 2055
- Date and Time: Friday, November 7 from 1:00-2:00 p.m. E.T.
Title: Reduction of Liver Fibrosis by AI-Based Digital Pathology Analysis: Results from the Pemvidutide Phase 2b IMPACT Trial (Late Breaking Abstract)
- Collaborator: Altimmune
- Poster Number: 5025
- Date and Time: Saturday, November 8 from 1:00-2:00 p.m. E.T.
- Collaborator: URV Biomedical Research Unit
- Poster Number: 2140
- Date and Time: Saturday, November 8 from 1:00-2:00 p.m. E.T.
- Collaborator: Akero
- Poster Number: 4085
- Date and Time: Monday, November 10 from 1:00-2:00 p.m. E.T.
*LiverExplore and AIM-MASH are For Research Use Only. Not for use in diagnostic procedures.
About PathAI
PathAI is a leading provider of integrated AI and digital pathology solutions dedicated to transforming workflow and operational efficiency in pathology labs worldwide. Through innovative technologies and strategic partnerships, PathAI aims to enhance patient outcomes and drive the future of medical diagnostics. For more information, visit www.pathai.com.
